HuniLife Biotechnology, Inc., was established in December 2013, headquartered in Neihu Sciences Park, Taipei City, Taiwan. HuniLife focuses on the new drug development for the treatment of cancer, immune disorders, and so on.. The company’s strategy is to create added values by validating the medicinal product in development from early discovery and preclinical development to clinical trials.